Coronary Artery Disease and Symptomatic Severe Aortic Valve Stenosis: Clinical Outcomes after Transcatheter Aortic Valve Implantation

Frontiers in Cardiovascular Medicine

Volumn 2, Issue , 2015, Pages

  Mancio, Jennifer ^a   Fontes Carvalho, Ricardo ^a,b   Oliveira, Marco ^a   Caeiro, Daniel ^a   Braga, Pedro ^a   Bettencourt, Nuno ^a,b   Ribeiro, Vasco Gama ^a  

^a Gaia Hospital Center   (Portugal)

^b University of Porto   (Portugal)

Author keywords

aortic valve stenosis; coronary disease; percutaneous coronary angioplasty intervention; prognosis; transcatheter aortic valve implantation

Indexed keywords

EID: 84979879749     PISSN: None     EISSN: 2297055X     Source Type: Journal    
DOI: 10.3389/fcvm.2015.00018     Document Type: Article

References (31)

1. Exadactylos N, Sugrue DD, Oakley CM. Prevalence of coronary artery disease in patients with isolated aortic valve stenosis. Br Heart J (1984) 51:121–4.10.1136/hrt.51.2.121
2. Lund O, Nielsen TT, Magnussen K, Pilegaard HK, Knudsen MA. Valve replacement for calcified aortic stenosis in septuagenarians infers normal life-length. Scand J Thorac Cardiovasc Surg (1991) 25:37–44.10.3109/140174391090980812063152
3. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines. J Thorac Cardiovasc Surg (2014) 148:e1–132.10.1016/j.jtcvs.2014.05.014
4. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012) The joint task force on the management of valvular heart disease of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS). Eur Heart J (2012) 33:2451–96.10.1093/eurheartj/ehs109
5. Dewey TM, Brown DL, Herbert MA, Culica D, Smith CR, Leon MB, et al. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg (2010) 89:758–67. Discussion 67,2017212310.1016/j.athoracsur.2009.12.033
6. Masson JB, Lee M, Boone RH, et al. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Catheter Cardiovasc Interv (2010) 76:165–73.10.1002/ccd.22501
7. Gautier M, Pepin M, Himbert D, Ducrocq G, Iung B, Dilly MP, et al. Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. EuroIntervention (2011) 7:549–55.10.4244/EIJV7I5A9021930458
8. Kodali SK, Moses JW. CAD and aortic stenosis in the TAVR era: old questions, new paradigms. The evolving role of PCI in the treatment of patients with aortic stenosis. Circulation (2012) 125(8):975–7.10.1161/CIRCULATIONAHA.111.087965
9. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Eng J Med (2010) 363:1597–607.10.1056/NEJMoa100823220961243
10. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European association of cardio-thoracic surgery (EACTS) and the European society of cardiology (ESC), in collaboration with the European association of percutaneous cardiovascular interventions (EAPCI). Eur Heart J (2008) 29:1463–70.
11. Goel SS, Agarwal S, Tuzcu EM, et al. Percutaneous coronary intervention in patients with severe aortic stenosis implications for transcatheter aortic valve replacement. Circulation (2012) 125:1005–13.10.1161/CIRCULATIONAHA.111.039180
12. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Eng J Med (2012) 366:1686–95.10.1056/NEJMoa120038422443479
13. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Eng J Med (2011) 364:2187–98.10.1056/NEJMoa110351021639811
14. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg (1999) 15:816–23.10.1016/S1010-7940(99)00106-210431864
15. Aranki SF, Adams DH, Rizzo RJ, Couper GS, Sullivan TE, Collins JJ, Jr. et al. Determinants of early mortality and late survival in mitral valve endocarditis. Circulation (1995) 92:II143–9.10.1161/01.CIR.92.9.1437586399
16. Gurvitch R, Toggweiler S, Willson AB, Wijesinghe N, Cheung A, Wood DA, et al. Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the valve academic research consortium (VARC) guidelines. EuroIntervention (2011) 7:41–8.10.4244/EIJV7I1A1021550902
17. Windecker S, et al. 2014 ESC/EACTS guidelines on myocardial revascularization the task force on myocardial revascularization of the european society of cardiology (ESC) and the european association for cardio-thoracic surgery (EACTS) developed with the special contribution of the european association of percutaneous cardiovascular interventions (EAPCI). Eur Heart J (2014) 35(37):2541–619.10.1093/eurheartj/ehu278
18. Boden WE, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, et al. Optimal medical therapy with or without pci for stable coronary disease. N Engl J Med (2007) 356(15):1503–16.10.1056/NEJMoa07082917387127
19. Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study: fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol (2010) 55(25):2816–21.10.1016/j.jacc.2009.11.09620579537
20. Samuels B, Kiat H, Friedman JD, Berman DS. Adenosine pharmacologic stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis: diagnostic efficacy and comparison of clinical, hemodynamic and electrocardiographic variables with 100 age-matched control subjects. J Am Coll Cardiol (1995) 25(1):99–106.10.1016/0735-1097(94)00317-J7798533
21. Clavel MA, Ennezat PV, Maréchaux S, Dumesnil JG, Capoulade R, Hachicha Z, et al. Stress echocardiography to assess stenosis severity and predict outcome in patients with paradoxical low-flow, low-gradient aortic stenosis and preserved LVEF. JACC Cardiovasc Imaging (2013) 6(2):175–83.10.1016/j.jcmg.2012.10.01523489531
22. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL. Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Eng J Med (1982) 307(22):1362–6.10.1056/NEJM1982112530722026215582
23. Weidemann F, Herrmann S, Störk S, Niemann M, Frantz S, Lange V, et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation (2009) 120(7):577–84.10.1161/CIRCULATIONAHA.108.84777219652094
24. Kim WK, Rolf A, Liebetrau C, Van Linden A, Blumenstein J, Kempfert J, et al. Detection of myocardial injury by CMR after transcatheter aortic valve replacement. J Am Coll Cardiol (2014) 64(4):349–57.10.1016/j.jacc.2014.03.05225060368
25. Freixa X, et al. Impact of coronary artery disease on left ventricular ejection fraction recovery following transcatheter aortic valve implantation. Catheter Cardiovasc Interv (2015) 85(3):450–8.10.1002/ccd.25632
26. Khawaja MZ, Asrress KN, Haran H, Arri S, Nadra I, Bolter K, et al. The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention (2014).10.4244/EIJY14M05_0924832041
27. Van Mieghem NM, et al. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. JACC Cardiovasc Interv (2013) 6(8):867–75.10.1016/j.jcin.2013.04.015
28. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol (2010) 55:1080–90.10.1016/j.jacc.2009.12.01420096533
29. Vahanian A, Alfieri OR, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European association of cardio-thoracic surgery (EACTS) and the European society of cardiology (ESC), in collaboration with the European association of percutaneous cardiovascular interventions (EAPCI). Eur J Cardiothorac Surg (2008) 34:1–8.
30. Abdel-Wahab M, Mostafa AE, Geist V, Stöcker B, Gordian K, Merten C, et al. Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention. Am J Cardiol (2012) 109:581–6.10.1016/j.amjcard.2011.09.05322133754
31. Wenaweser P, Pilgrim T, Guerios E, et al. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention (2011) 7:541–8.10.4244/EIJV7I5A89